Strahlentherapie und Onkologie

Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer—a meta-analysis

Jan Haussmann, Bálint Tamaskovics, Edwin Bölke, Freddy-Joel Djiepmo-Njanang, Kai Kammers, Stefanie Corradini, Matthias Hautmann, Pirus Ghadjar, Kitti Maas, Patrick J. Schuler, Thomas K. Hoffmann, Guido Lammering, Wilfried Budach, Christiane Matuschek

Outcome and management of rare high-grade “salivary” adenocarcinoma: the important role of adjuvant (chemo)radiotherapy

Claudia Scherl, Marlen Haderlein, Abbas Agaimy, Konstantinos Mantsopoulos, Michael Koch, Maximilian Traxdorf, Rainer Fietkau, Philipp Grundtner, Heinrich Iro

Re-irradiation for osteoarthritis—retrospective analysis of 217 joints

Matthias G. Hautmann, Philipp Rechner, Matthias Hipp, Ulrich Neumaier, Felix Steger, Fabian Pohl, Markus Weber, Oliver Kölbl, Christoph Süß

Radiotherapy for painful benign skeletal disorders

Nderim Juniku, Oliver Micke, M. Heinrich Seegenschmiedt, Ralph Muecke

Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy

Tilman Bostel, Robert Förster, Ingmar Schlampp, Tanja Sprave, Sati Akbaba, Daniel Wollschläger, Jürgen Debus, Arnulf Mayer, Heinz Schmidberger, Harald Rief, Nils Henrik Nicolay

Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline—is the risk of relevant errors overestimated?

Felix Steger, Matthias G. Hautmann, Christoph Süß, Ute Hubauer, Ekrem Ücer, Lars Maier, Oliver Kölbl, Carsten Jungbauer

Automatic image segmentation based on synthetic tissue model for delineating organs at risk in spinal metastasis treatment planning

Olaf Wittenstein, Patrick Hiepe, Lars Henrik Sowa, Elias Karsten, Iris Fandrich, Juergen Dunst

Successful integration of radiation oncology in preclinical medical education

Michael Oertel, Martina Schmitz, Jan Carl Becker, Hans Theodor Eich, Anna Schober

Dosis-Deeskalation der adjuvanten Radiochemotherapie bei HPV-positiven Oropharynxkarzinomen: die MC1273-Phase-II-Studie

Alexander Rühle, Nils H. Nicolay

Lokal konsolidierende Strahlentherapie beim oligometastasierten Nicht-kleinzelligen Bronchialkarzinom

Alexander Fabian, Florian Pyschny, David Krug

Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar I

Ping Jiang, Oliver Blanck, Jürgen Dunst

Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar II

Gregor Goldner

23rd annual SASRO meeting